Treatment with oral urea in patients with heart failure and chronic hyponatremia

Authors

DOI:

https://doi.org/10.32818/reccmi.a9s1a4

Keywords:

hyponatremia, heart failure, diuretics, urea

Abstract

Hyponatremia is the most common water-electrolyte disorder in patients with heart failure. The presence of hyponatremia is associated with a less favourable prognosis, a longer hospital stays, higher readmission rates, increased long-term morbidity and a poorer response to depletive treatment.

There are several potential causes for hyponatremia in this clinical context. Inappropriate antidiuretic hormone secretion and the concomitant use of diuretics are contributing factors. This represents a significant challenge regarding clinical management. The most common form of presentation is chronic and mild, and currently there is a lack of high-quality, evidence-based studies available to inform the most appropriate treatment approach.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Rondon-Berrios H. Urea for chronic hyponatremia. Blood Purif. 2020; 49(1-2): 212-218. doi: https://doi.org/10.1159/000503773 (último acceso sept. 2024). DOI: https://doi.org/10.1159/000503773

Martínez González Á, Rodeiro Escobar P, Llópiz Castedo J, Díaz Vázquez M, Sánchez Juanas FL, Villar Carballo M, et al. Efectividad de la administración de urea para el tratamiento de la hiponatremia en la insuficiencia cardiaca. Med Clin (Barc). 2024; 162(2): 56-59. doi: https://doi.org/10.1016/j.medcli.2023.08.001 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.medcli.2023.08.001

Mondellini GM, Verbrugge FH. Evaluation and management of hyponatremia in heart failure. Curr Heart Fail Rep. 2024; 21(3): 252-261. doi: https://doi.org/10.1007/s11897-024-00651-3 (último acceso sept. 2024). DOI: https://doi.org/10.1007/s11897-024-00651-3

Hammonds WM, Keating EA, Smetana ME, Smetana KS, Bond MM. Safety and efficacy of urea for hyponatremia. Hosp Pharm. 2022; 57(3): 365-369. doi: https://doi.org/10.1177/00185787211037548 (último acceso sept. 2024). DOI: https://doi.org/10.1177/00185787211037548

Lockett J, Berkman KE, Dimeski G, Russell AW, Inder WJ. Urea treatment in fluid restriction-refractory hyponatraemia. Clin Endocrinol (Oxf). 2019; 90(4): 630-636. doi: https://doi.org/10.1111/cen.13930 (último acceso sept. 2024). DOI: https://doi.org/10.1111/cen.13930

Nervo A, D'Angelo V, Rosso D, Castellana E, Cattel F, Arvat E, Grossi E. Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence. Clin Endocrinol (Oxf). 2019; 90(6): 842-848. doi: https://doi.org/10.1111/cen.13966 (último acceso sept. 2024). DOI: https://doi.org/10.1111/cen.13966

Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol. 2012; 7(5): 742-747. doi: https://doi.org/10.2215/CJN.06990711 (último acceso sept. 2024). DOI: https://doi.org/10.2215/CJN.06990711

Published

2024-11-30

How to Cite

1.
Villarejo-Elena C, Pacheco-Yepes MR, Pérez-Belmonte LM, Gómez-Huelgas R. Treatment with oral urea in patients with heart failure and chronic hyponatremia. Rev Esp Casos Clin Med Intern [Internet]. 2024 Nov. 30 [cited 2024 Dec. 26];9(Supl. 1):8-10. Available from: https://www.reccmi.com/RECCMI/article/view/1057

Most read articles by the same author(s)

1 2 > >>